Myeloid monocyte leukemia
Myelomonocytic leukemia (AMMOL) accounts for 25% of all non-lymphocytic leukemia cases. Specific skin damage is rare and only a few cases have been reported.
The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.